- New
-
Topics
- All Categories
- Metaphysics and Epistemology
- Value Theory
- Science, Logic, and Mathematics
- Science, Logic, and Mathematics
- Logic and Philosophy of Logic
- Philosophy of Biology
- Philosophy of Cognitive Science
- Philosophy of Computing and Information
- Philosophy of Mathematics
- Philosophy of Physical Science
- Philosophy of Social Science
- Philosophy of Probability
- General Philosophy of Science
- Philosophy of Science, Misc
- History of Western Philosophy
- Philosophical Traditions
- Philosophy, Misc
- Other Academic Areas
- Journals
- Submit material
- More
Monoamine receptor sensitivity and antidepressants
Behavioral and Brain Sciences 5 (1):107-108 (1982)
Abstract
This article has no associated abstract. (fix it)My notes
Similar books and articles
Problems with current catecholamine hypotheses of antidepressant agents: Speculations leading to a new hypothesis.Eric A. Stone - 1983 - Behavioral and Brain Sciences 6 (4):535.
Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials? [REVIEW]John P. A. Ioannidis - 2008 - Philosophy, Ethics, and Humanities in Medicine 3:14.
The insulin receptor changes conformation in unforeseen ways on ligand binding: Sharpening the picture of insulin receptor activation.Colin W. Ward, John G. Menting & Michael C. Lawrence - 2013 - Bioessays 35 (11):945-954.
Stone's revised aminergic hypothesis and the functional significance of receptor binding sensitivity.Richard J. Katz - 1983 - Behavioral and Brain Sciences 6 (4):555.
The ethics of self-change: becoming oneself by way of antidepressants or psychotherapy? [REVIEW]Fredrik Svenaeus - 2009 - Medicine, Health Care and Philosophy 12 (2):169-178.
The necessity and the value of placebo.Dr Ernst A. Singer - 2004 - Science and Engineering Ethics 10 (1):51-56.
Ligand‐induced activation of the insulin receptor: a multi‐step process involving structural changes in both the ligand and the receptor.Colin W. Ward & Michael C. Lawrence - 2009 - Bioessays 31 (4):422-434.
Placebo in the investigation of psychotropic drugs, especially antidepressants.Stanisław Pużyński - 2004 - Science and Engineering Ethics 10 (1):135-142.
Treating Yourself as an Object: Self-Objectification and the Ethical Dimensions of Antidepressant Use.Ginger A. Hoffman - 2012 - Neuroethics 6 (1):165-178.
No blind schizophrenics: Are NMDA-receptor dynamics involved?Glenn S. Sanders, Steven M. Platek & Gordon G. Gallup - 2003 - Behavioral and Brain Sciences 26 (1):103-104.
Analytics
Added to PP
2014-01-20
Downloads
15 (#893,994)
6 months
1 (#1,459,555)
2014-01-20
Downloads
15 (#893,994)
6 months
1 (#1,459,555)
Historical graph of downloads
References found in this work
Neuroleptics and operant behavior: The anhedonia hypothesis.Roy A. Wise - 1982 - Behavioral and Brain Sciences 5 (1):39-53.
Bodily Changes in Pain, Hunger, Fear, and Rage.Walter B. Cannon - 1917 - Journal of Philosophy, Psychology and Scientific Methods 14 (3):79-80.
Précis of The evolution of human sexuality.Donald Symons - 1980 - Behavioral and Brain Sciences 3 (2):171-181.
Consequences of commitment to and disengagement from incentives.Eric Klinger - 1975 - Psychological Review 82 (1):1-25.
Cholinergic mechanisms in the control of behavior by the brain.Peter L. Carlton - 1963 - Psychological Review 70 (1):19-39.
PhilPapers logo by Andrea Andrews and Meghan Driscoll.
This site uses cookies and Google Analytics (see our terms & conditions for details regarding the privacy implications). Use of this site is subject to terms & conditions.
All rights reserved by The PhilPapers Foundation
Server: philpapers-web-7c76586df8-4c2ch uwo